Assessment of HER2 Status in Breast Cancer Biopsies Is Not Affected by Accelerated Tissue Processing

Histopathology - United Kingdom
doi 10.1111/his.13507
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines

JAMA Oncology
Cancer ResearchOncology
2019English

Reproducibility in the Assessment of HER2 DISH in Breast Cancer

The Bangkok Medical Journal
2015English

ID3014 Evaluation of HER2 Status in Breast Cancer: Current Status and Future Directions

Biomedical Research and Therapy
BiochemistryMedicineGeneticsMolecular Biology
2017English

HER2-HER3 Dimer Quantification by FLIM-FRET Predicts Breast Cancer Metastatic Relapse Independently of HER2 IHC Status

Oncotarget
Oncology
2016English

ZEB1 Is Involved in Regulating HER2-positive Breast Cancer Radiosensitivity by Controlling EMT

Oncology Letters
Cancer ResearchOncology
2018English

Accuracy of HER2 Status Determination on Breast Core-Needle Biopsies (Immunohistochemistry, FISH, CISH and SISH vs FISH)

Modern Pathology
Forensic MedicinePathology
2012English

Breast Cancer Subtypes Among Iraqi Patients: Identified by Their ER, PR and HER2 Status

Journal of the faculty of medicine baghdad
2017English

Erratum To: NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Is Enhanced by Tamoxifen in HER2/neu Non-Amplified, but Not HER2/neu-amplified, Breast Cancer Cells

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2016English

Is “Liquid Biopsy” Useful for Assessing HER2 Status in Gastric Cancer?

Journal of Gastroenterology
Gastroenterology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy